{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T04:37:24Z","timestamp":1722141444986},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.24358","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:34:11Z","timestamp":1604594051000},"page":"e2024358","source":"Crossref","is-referenced-by-count":4,"title":["Trends in Positive <i>BRCA<\/i> Test Results Among Older Women in the United States, 2008-2018"],"prefix":"10.1001","volume":"3","author":[{"given":"Fangjian","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Center for Interdisciplinary Research in Women\u2019s Health, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Scholl","sequence":"additional","affiliation":[{"name":"School of Medicine, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika L.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Center for Interdisciplinary Research in Women\u2019s Health, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Wong","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research in Women\u2019s Health, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Department of Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Research in Women\u2019s Health, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Department of Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Office of Biostatistics, Department of Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Institute for Translational Science, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbey B.","family":"Berenson","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston"},{"name":"Center for Interdisciplinary Research in Women\u2019s Health, The University of Texas Medical Branch at Galveston, Galveston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"issue":"4","key":"zoi200801r1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi200801r3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi200801r4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199601183340302","article-title":"Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.","volume":"334","author":"FitzGerald","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi200801r5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.amepre.2017.01.027","article-title":"Use of BRCA mutation test in the U.S., 2004-2014.","volume":"52","author":"Guo","year":"2017","journal-title":"Am J Prev Med"},{"issue":"2","key":"zoi200801r6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/cncr.v126.2","article-title":"BRCA testing in unaffected young women in the United States, 2006-2017.","volume":"126","author":"Guo","year":"2020","journal-title":"Cancer"},{"issue":"4","key":"zoi200801r7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/M13-1684","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.","volume":"160","author":"Nelson","year":"2014","journal-title":"Ann Intern Med"},{"issue":"9","key":"zoi200801r8","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.6004\/jnccn.2014.0127","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, version 1.2014.","volume":"12","author":"Daly","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"zoi200801r9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.6004\/jnccn.2006.0016","article-title":"Genetic\/familial high-risk assessment: breast and ovarian.","volume":"4","author":"Daly","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"zoi200801r10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.6004\/jnccn.2010.0043","article-title":"Genetic\/familial high-risk assessment: breast and ovarian.","volume":"8","author":"Daly","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"zoi200801r11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.","volume":"28","author":"Robson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi200801r13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"zoi200801r14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"12","key":"zoi200801r15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","article-title":"BRCA mutations in the management of breast cancer: the state of the art.","volume":"7","author":"Narod","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"zoi200801r16","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J Clin Oncol"},{"issue":"30","key":"zoi200801r17","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi200801r18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.ajog.2016.02.011","article-title":"Underuse of BRCA testing in patients with breast and ovarian cancer.","volume":"214","author":"Wright","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"zoi200801r19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.","volume":"13","author":"Levy","year":"2011","journal-title":"Genet Med"},{"key":"zoi200801r2","unstructured":"U.S. Preventive Services Task Force. The guide to clinical preventive services 2014. Accessed August 26, 2016. https:\/\/www.ahrq.gov\/sites\/default\/files\/wysiwyg\/professionals\/clinicians-providers\/guidelines-recommendations\/guide\/cpsguide.pdf"},{"key":"zoi200801r12","unstructured":"National Comprehensive Cancer Network: NCCN clinical practice guidelines in oncology: genetic\/familial high-risk assessment: breast and ovarian. Version 1.2018. Accessed October 5, 2017. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2772534\/guo_2020_oi_200801_1603750462.76396.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T16:34:24Z","timestamp":1604594064000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2772534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.24358","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,5]]}}}